Peripheral arterial disease (PAD): Nursing process (ADPIE)

1,404views

Peripheral arterial disease (PAD): Nursing process (ADPIE)

Synthesis Of Nursing Practice

Synthesis Of Nursing Practice

Left-sided heart failure: Nursing process (ADPIE)
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Normal heart sounds
Abnormal heart sounds
Anatomy of the heart
Congenital heart defects: Clinical
Cardiac conduction system
Post-COVID syndrome: Heart, lungs and clotting
Heart blocks: Pathology review
Aortic aneurysm: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Myocardial infarction (MI): Nursing process (ADPIE)
Pericardial effusion and cardiac tamponade: Nursing process (ADPIE)
Rheumatic heart disease: Nursing process (ADPIE)
Antihyperlipidemics - Statins: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Medications affecting the parathyroid glands: Nursing pharmacology
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Glucocorticoids and mineralocorticoids: Nursing pharmacology
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Urinary tract infections (UTIs): Nursing process (ADPIE)
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Sickle cell disease: Nursing process (ADPIE)
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Blood products: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Plant extracts for chemotherapy: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Alkylating agents: Nursing pharmacology
Hormones and hormone modulators for cancer: Nursing pharmacology
Other antineoplastics: Nursing pharmacology
Antimetabolites: Nursing pharmacology
Platinum-based agents: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Candidiasis: Nursing process (ADPIE)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Applying sterile gloves
Cardioversion
Maintaining an airway
Removing an intravenous line
Venipuncture for blood sampling
Clinical Skills: Abdominal Assessment
Clinical skills: Medication administration - Giving transcutaneous medication
Clinical skills: Patient controlled analgesia
COVID-19: Nursing

Notes

PERIPHERAL ARTERIAL DISEASE (PAD)

KEY POINTS
NOTES
PATIENT REPORT
  • 68-year-old 
  • Vascular clinic
  • History: type 2 diabetes, hypertension, and dyslipidemia
  • Reports intermittent leg pain while walking
  • Diagnosis: PAD

PATHOPHYSIOLOGY
  • Progressive narrowing of peripheral arteries 
    • Affects all arteries except heart and brain 
    • Leads to reduced blood supply 
      • Tissue ischemia 
  • Risk factors  
    • Nonmodifiable  
      • Increasing age 
      • Biological male sex 
      • Family history of PAD 
    • Modifiable  
      • Smoking 
      • Obesity 
      • Sedentary lifestyle 
      • Diabetes 
      • Dyslipidemia 
      • Hypertension 
  • Cause  
    • Atherosclerosis 
      • Buildup of fatty and fibrous material 
      • Plaque forms under inner vessel lining 
      • Develops over years 
    • Pathophysiology 
      • Vessel lumen narrows 
      • Perfusion to tissue decreases 
      • Embolism can worsen PAD 
      • Embolus from upstream artery 
      • Lodges in narrower peripheral artery 
      • Blocks blood flow 
    • Commonly affected areas 
      • Most often affects leg arteries 
      • Causes ischemia in leg muscles 
      • Leads to intermittent claudication 
    • Symptoms  
      • Symptoms appear with activity 
      • Muscle demand increases with exercise 
      • Anaerobic metabolism occurs 
      • Lactic acid builds up 
        • Pain usually in calves 
        • Can affect feet thighs hips buttocks 
      • Paresthesia tingling or numbness 
      • Decreased or absent pulses 
      • Cool extremities 
      • Muscle atrophy 
      • Hair thinning or loss 
      • Skin color changes 
      • Elevation pallor 
      • Burning or pain in forefoot and toes 
      • Pain worsens with leg elevation 
      • Pain relieved when legs lowered 
      • Foot turns red when lowered 
        • Dependent rubor 
  • Complications 
    • Nerve damage 
    • Peripheral neuropathy 
    • Loss of sensation 
    • Tissue necrosis 
    • Nonhealing wounds or ulcers 
    • Risk of gangrene 
    • Risk of amputation

DIAGNOSIS AND TREATMENT
  • Diagnosis
    • History
    • Physical assessment
    • Ankle brachial index (ABI)
    • Diagnostic imaging
  • Treatment
    • Lifestyle changes 
      • Quit smoking 
      • Lose weight 
      • Eat healthy 
      • Exercise regularly 
      • Manage diabetes and hypertension 
    • Medications  
      • Antiplatelet drugs
    • Revascularization  
      • Percutaneous intervention 
      • Surgical bypass 
    • If gangrenous, requires tissue removal 
    • Amputation 

ASSESSMENT
  • Legs are hairless and ruddy 
  • Reports worsening leg pain over past year 
  • Describes pain as severe aching cramps during walks 
  • Pain improves with rest 
  • Smokes one pack of cigarettes per week 
  • No specific diet followed 
  • Physical examination 
    • Legs become pale when lying down 
    • Femoral pulses 3+ bilaterally 
    • Popliteal pulses 2+ bilaterally 
    • Posterior tibial pulses 1+ bilaterally 
    • Dorsalis pedis pulses 1+ bilaterally 
    • Feet are cool to touch 
    • Capillary refill > 3 seconds bilaterally 
    • Toenails are thickened 
    • No impaired skin integrity noted 
  • Vital signs 
    • Temperature: 98.4°F (36.8°C) 
    • Heart rate: 78 bpm 
    • Respiratory rate: 18 bpm 
    • Blood pressure: 152/80 mmHg 
    • Pain: 0/10 
    • SpO2: 97% room air 
  • Weight: 205 lbs (93 kg)
  • Height: 5 ft 10 in (177 cm)
  • Diagnostic/lab results 
    • Hemoglobin A1c: 9.2% 
    • Total cholesterol: 249 mg/dL (6.4 mmol/L) 
    • Triglycerides: 160 mg/dL (1.8 mmol/L)
    • LDL: 163 mg/dL (4.2 mmol/L)
    • HDL: 30 mg/dL (0.78 mmol/L)
    • Right ABI: 0.63 
    • Left ABI: 0.58

NURSING DIAGNOSES
  • Ineffective peripheral tissue perfusion related to vascular dysfunction
  • Activity intolerance related to muscle pain and fatigue while walking
  • Risk for impaired skin integrity related to insufficient perfusion to lower extremities
  • Ineffective health maintenance related to disease progression

PLANNING
  • Before leaving clinic today
    • Patient will commit to lifestyle modifications and adherence to treatment plan
  • At follow-up appointment in six months, 
    • Patient will report ability to take walks with dog w/o pain
    • Patient will have adequate tissue perfusion and maintain intact skin on lower extremities; 

IMPLEMENTATION
  • Prescribed cilostazol 
  • Increased dose of lisinopril  
  • Continue other current medications 
    • Aspirin 
    • Atorvastatin 
    • Metformin 
  • Patient education 
    • Importance of quitting smoking 
    • Control blood glucose levels 
    • Maintain healthy blood pressure 
    • Manage cholesterol levels  
    • Follow diabetic diet 
    • Engage in regular exercise 
    • Daily inspection of lower extremities and feet
    • Watch for skin breakdown, sores, or ulcers
    • Report to HCP worsening leg pain or rest pain or sores
  • Appointment with diabetic educator 
  • Referral to smoking cessation support group 

EVALUATION
  • Reports no pain or fatigue during daily dog walks 
  • Taking medications as prescribed 
  • Following structured exercise and nutrition plan 
  • Monitoring blood glucose regularly 
  • Attending smoking cessation support group 
  • Has not smoked in 3 months 
  • Hemoglobin A1c: 8.4% 
  • Total cholesterol: 177 mg/dL (4.5 mmol/L)
  • Triglycerides: 99 mg/dL (1.1 mmol/L)
  • LDL: 95 mg/dL (2.4 mmol/L)
  • HDL: 62 mg/dL (1.6 mmol/L)
  • Blood pressure: 126/72 mmHg 
  • Skin on lower extremities intact

Transcript

Watch video only

Mike Craig is a 68-year-old male client who is referred to the vascular clinic by his primary care provider, or PCP. Mr. Craig has a history of type 2 diabetes, hypertension, and dyslipidemia, and he’s been experiencing intermittent leg pain in his lower legs while taking walks with his dog.

An ankle-brachial index, or ABI, is performed which confirmed a diagnosis of peripheral artery disease, or PAD. Peripheral arterial disease, or PAD for short, is the progressive narrowing of the arteries that supply peripheral tissues and organs, so basically all arteries except for the heart and brain.

As a result, there’s reduced blood supply to these tissues, which ultimately become ischemic. There are some factors that may put an individual at risk for PAD.

Non-modifiable risk factors include increasing age, male sex, and having a family history of PAD. On the other hand, modifiable risk factors include smoking, obesity, and having a sedentary life, as well as predisposing conditions like diabetes, dyslipidemia, and hypertension.

The most common cause of PAD is atherosclerosis, which is a buildup of fatty and fibrous material just under the inner lining of a blood vessel, forming a plaque.

This buildup usually happens over the course of years. Eventually, the lumen of the vessel becomes so narrow that it results in reduced perfusion to the tissue it tends to supply.

PAD can be worsened by an embolism. This happens when an embolus, which is a piece of blood clot or fatty deposit, breaks off from an atherosclerotic plaque from an upstream artery, and gets lodged in a narrower peripheral artery, blocking its blood flow.

Now, in most cases PAD affects the arteries supplying the legs. When less blood gets to the muscle tissue in the legs, that tissue becomes ischemic, causing a type of cramping pain that is often referred to as intermittent claudication.

Initially though, when the client’s at rest, there’s enough blood to meet the tissue’s demands, so they’ll be asymptomatic. But if the client starts walking or exercising, then the leg muscles start to work harder and demand more blood, which causes the claudication.

In addition, since the muscles aren’t getting enough oxygen from blood, they’ll switch from aerobic to anaerobic metabolism, and the production of lactic acid, which will build up and contribute to the pain.

This is usually felt in the calves, but can also involve the feet, thighs, hips, or buttocks. Other signs and symptoms of PAD include paresthesia, which is described as tingling or numbness, as well as decreased or absent pulses, cool extremities, and atrophy of the muscles.

In addition, clients may present with hair thinning or loss over the affected skin area, as well as skin color changes, which may become pale or bluish, especially when the leg is elevated, which is called elevation pallor.

As the PAD worsens, clients may start experiencing claudication even at rest. The client often describes this as a continuous burning or pain in the forefoot and toes that gets worse when the legs are elevated, and is relieved when they’re lowered, like hanging the feet over the bed, because gravity is working with the blood flow in this direction.

Likewise, the foot might turn red when it’s lowered, which is called dependent rubor. Ultimately, the reduced blood flow can lead to nerve damage, which results in peripheral neuropathy, where the client loses sensation in the affected tissue.

Moreover, the tissue can become necrotic and develop wounds or ulcers that don’t heal, and the limb might be at risk of gangrene and amputation.Diagnosis of PAD relies largely on the client’s history and physical examination.

A quick and noninvasive test is the ankle-brachial index, or ABI for short, where blood pressure is taken in the ankle and in the arm, and then compared. PAD is typically diagnosed if the systolic blood pressure in the ankle divided by the systolic blood pressure in the arm is less than 0.9.

In general, claudication often occurs in clients with an ABI between 0.4 and 0.9, rest pain is seen between 0.2 and 0.4, and ulcers, and gangrene between 0 to 0.4.

Diagnosis of PAD can also involve listening to the pulse in the involved arteries with a stethoscope, so for example in the legs, it would be the iliac arteries. With PAD, the narrowed artery would make a whooshing sound, called a bruit.

Another test that can be done is a doppler ultrasound, which is a way of visualizing blood-flow. Rarely, an angiography might be needed to confirm the diagnosis, by using X-rays and a contrast agent to assess the blood flow in the involved arteries.

Treatment of PAD often requires lifestyle changes that address the underlying risk factors. Clients should quit smoking, lose weight, adopt healthy eating habits, and exercise regularly; as well as managing any associated condition like diabetes and hypertension.

Some clients with PAD can also take certain medications to help reduce blood clotting, such as antiplatelet medications like aspirin or clopidogrel. Clients who fail to respond to these treatments can be treated with revascularization to reestablish arterial blood flow.

Revascularization options include percutaneous intervention or surgical bypass. Finally, clients who present with gangrene require removal of necrotic tissue, and in some cases, the limb would have to be amputated.

Sources

  1. "Epidemiology and Risk of Amputation in Patients with Diabetes Mellitus and Peripheral Artery Disease" Arterioscler Thromb Vasc Biol (2020)
  2. "Evidence-Based Medical Management of Peripheral Artery Disease" Arterioscler Thromb Vasc Biol (2020)
  3. "Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement from the American Heart Association" Circulation (2021)
  4. "Antithrombotic Treatment for Peripheral Arterial Occlusive Disease" Dtsch Arztebl Int (2021)
  5. "Harrison’s Principles of Internal Medicine, 21st edition" McGraw Hill / Medical (2022)
  6. "Critical Care Nursing: Diagnosis and Management, 9th edition" Elsevier (2021)
  7. "Health Assessment for Nursing Practice, 7th edition" Elsevier (2021)